中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2011年
2期
127-131
,共5页
狄晴%王凌玲%许利刚%余年%蒋颖%江炜炜%孙丰%葛剑青%张颖冬
狄晴%王凌玲%許利剛%餘年%蔣穎%江煒煒%孫豐%葛劍青%張穎鼕
적청%왕릉령%허리강%여년%장영%강위위%손봉%갈검청%장영동
癫痫%药物抵抗%P-糖蛋白%多药耐药基因%基因多态性
癲癇%藥物牴抗%P-糖蛋白%多藥耐藥基因%基因多態性
전간%약물저항%P-당단백%다약내약기인%기인다태성
Epilepsy%Drug-resistance%P-glycoprotein%Multidrug resistance gene%Genetic polymorphism
目的 探讨多药耐药基因1(MDR1)C3435T位点多态性与汉族难治性癫痫(RE)的关系. 方法 收集170例诊断明确、治疗合理的汉族癫痫患者,根据是否符合RE诊断标准将其分为RE组(91例)和非RE组(79例).RE定义为:至少观察2年,按患者发作类型正确使用≥2种对该发作类型有效的抗癫痫药物,单药前、后分别使用或联合使用,仍每月发作≥1次达2年及以上者.采用多聚酶链反应限制性片段长度多态性方法检测患者外周血MDR1基因C3435T多态性. 结果 RE组CC、CT、TT基因型分别占48.4%、40.7%、11.0%,非RE组分别占40.5%、38.0%、21.5%,总体差异无统计学意义(x2=3.615,P=0.164).RE组患者C3435T等位基因C、T频率分别为68.7%、31.3%,非RE组患者分别为59.5%、40.5%,差异也无统计学意义(x2=3.112,P=0.080).根据病因将患者分为原发性癫痫、症状性或隐源性癫痫2组,结果示2组患者中RE亚组和非RE亚组C3435T基因型分布、等位基因频率差异均无统计学意义(P>0.05). 结论 本研究未发现MDR1基因C3435T多态性与汉族RE有关.
目的 探討多藥耐藥基因1(MDR1)C3435T位點多態性與漢族難治性癲癇(RE)的關繫. 方法 收集170例診斷明確、治療閤理的漢族癲癇患者,根據是否符閤RE診斷標準將其分為RE組(91例)和非RE組(79例).RE定義為:至少觀察2年,按患者髮作類型正確使用≥2種對該髮作類型有效的抗癲癇藥物,單藥前、後分彆使用或聯閤使用,仍每月髮作≥1次達2年及以上者.採用多聚酶鏈反應限製性片段長度多態性方法檢測患者外週血MDR1基因C3435T多態性. 結果 RE組CC、CT、TT基因型分彆佔48.4%、40.7%、11.0%,非RE組分彆佔40.5%、38.0%、21.5%,總體差異無統計學意義(x2=3.615,P=0.164).RE組患者C3435T等位基因C、T頻率分彆為68.7%、31.3%,非RE組患者分彆為59.5%、40.5%,差異也無統計學意義(x2=3.112,P=0.080).根據病因將患者分為原髮性癲癇、癥狀性或隱源性癲癇2組,結果示2組患者中RE亞組和非RE亞組C3435T基因型分佈、等位基因頻率差異均無統計學意義(P>0.05). 結論 本研究未髮現MDR1基因C3435T多態性與漢族RE有關.
목적 탐토다약내약기인1(MDR1)C3435T위점다태성여한족난치성전간(RE)적관계. 방법 수집170례진단명학、치료합리적한족전간환자,근거시부부합RE진단표준장기분위RE조(91례)화비RE조(79례).RE정의위:지소관찰2년,안환자발작류형정학사용≥2충대해발작류형유효적항전간약물,단약전、후분별사용혹연합사용,잉매월발작≥1차체2년급이상자.채용다취매련반응한제성편단장도다태성방법검측환자외주혈MDR1기인C3435T다태성. 결과 RE조CC、CT、TT기인형분별점48.4%、40.7%、11.0%,비RE조분별점40.5%、38.0%、21.5%,총체차이무통계학의의(x2=3.615,P=0.164).RE조환자C3435T등위기인C、T빈솔분별위68.7%、31.3%,비RE조환자분별위59.5%、40.5%,차이야무통계학의의(x2=3.112,P=0.080).근거병인장환자분위원발성전간、증상성혹은원성전간2조,결과시2조환자중RE아조화비RE아조C3435T기인형분포、등위기인빈솔차이균무통계학의의(P>0.05). 결론 본연구미발현MDR1기인C3435T다태성여한족RE유관.
Objective To clarify the relation between the C3435T polymorphism of multidrug resistance 1 (MDR1) gene and human refractory epilepsy (RE) in ethnic Han Chinese. Methods We collected 170 patients with epilepsy, whose diagnoses were correct and treatments were reasonable. RE was defined as having uncontrolled seizures that occurred with an average frequency of at least once a month for a period of at least 2 years; during the 2-years period, at least 2 different antiepileptic drugs (AEDs) were used daily, either singly or in combination. According to the definition, 91 patients were classified into RE group and the other 79 patients into non-RE group. A 5-mL venous blood sample was taken from the patients for DNA extraction and genotyping. Genotype of C3435T polymorphism in MDR1 gene was determined by polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP). Results The distribution of CC, CT, TT genotypes was 48.4%, 40.7%,11.0% in RE group, and 40.5%, 38.0%, 21.5% in non-RE group, respectively; no significant differences of C3435T genotype were noted between the 2 groups (x2=3.615, P=0.164). The C and T allele frequencies were 68.7%, 31.3% in RE group, and 59.5%, 40.5% in non-RE group, respectively; no significant differences were found between 2 groups (x2=3.112, P=0.080). Patients were divided into primary epilepsy group and cryptogenic or symptomatic epilepsy group according to the etiology;analyses of the genotype and allele of C3435T in the sub-groups (RE and non-RE subgroups) of this 2 groups were similarly unremarkable. Conclusion No association between the C3435T polymorphism in MDR1 gene and RE in ethnic Han Chinese is noted.